Enzo Biochem (ENZ) has released an update to notify the public and investors about a regulation fd disclosure.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
On February 1, 2024, the Company publicly shared the outcomes of the 2023 Annual Meeting through a press release. The detailed press release is provided as part of the official records but is not considered legally “filed” under the Securities Exchange Act of 1934, nor is it liable under that act, and it should not be assumed to be part of any filings under the Securities Act of 1933 or the Exchange Act unless explicitly referenced in those filings.
For further insights into ENZ stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
